Used in pharmaceutical synthesis, particularly in the development of angiotensin II receptor antagonists for treating hypertension and heart failure. Acts as a key intermediate in constructing tetrazole-containing drug molecules due to its ability to participate in Suzuki-Miyaura cross-coupling reactions. The boronic acid group enables carbon-carbon bond formation, while the tetrazole moiety contributes to biological activity by mimicking carboxylic acid groups in bioactive compounds. Also employed in medicinal chemistry research for designing protease inhibitors and other bioactive agents.